See also this year's filing and all EDGAR filings for this company.
PDF Report 0000715446_2018_Anixa_Biosciences_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.8318377583636087, 'aggregate_val': 889493, 'exp_sum': 5289493, 'exp_to_value': {'LiabilitiesCurrent': 889493, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 4400000}} |
Graph
Absolute values for 0000715446, Anixa Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,013,940 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 52,701 |
| 3 | remainder_Assets | 1,745,775 |
| 4 | LiabilitiesCurrent | 889,493 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,410,682 |
| 9 | ResearchAndDevelopmentExpense | 1,597,550 |
| 10 | remainder_Expenses | 930,307 |
| 11 | remainder_Revenues | 362,500 |
| 12 | remainder_NetIncome | 1,567,048 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,812,416 |
| 1 | Liabilities | 889,493 |
| 2 | Expenses | 6,938,539 |
| 3 | Revenues | 362,500 |
| 4 | StockholdersEquity | 7,922,923 |
| 5 | NetIncome | -5,008,991 |
| 6 | ComprehensiveNetIncome | -5,008,991 |
| 7 | BaseVar | 9,284,998 |
| 8 | EconomicCapitalRatio | 1.78 |
Edgar->Model Mapping
Feature Distribution
Change over Time
